KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.03 $5.34 Friday, 26th Apr 2024 BCRX stock ended at $4.16. During the day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26.
90 days $4.03 $6.35
52 weeks $4.03 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Apr 12, 2016 $2.89 $2.95 $2.75 $2.83 748 646
Apr 11, 2016 $2.89 $3.00 $2.87 $2.90 876 102
Apr 08, 2016 $2.87 $2.91 $2.84 $2.88 1 278 266
Apr 07, 2016 $2.79 $2.93 $2.73 $2.84 1 554 436
Apr 06, 2016 $2.72 $2.81 $2.67 $2.80 1 655 636
Apr 05, 2016 $2.77 $2.82 $2.70 $2.72 951 966
Apr 04, 2016 $2.85 $2.93 $2.76 $2.80 904 122
Apr 01, 2016 $2.82 $2.92 $2.77 $2.83 875 741
Mar 31, 2016 $2.73 $2.89 $2.73 $2.83 1 538 932
Mar 30, 2016 $2.75 $2.87 $2.69 $2.75 931 956
Mar 29, 2016 $2.74 $2.75 $2.48 $2.71 1 086 600
Mar 28, 2016 $2.80 $2.84 $2.62 $2.76 817 200
Mar 24, 2016 $2.60 $2.81 $2.56 $2.79 1 083 600
Mar 23, 2016 $2.87 $2.97 $2.61 $2.62 1 199 300
Mar 22, 2016 $2.76 $2.95 $2.74 $2.87 938 700
Mar 21, 2016 $2.64 $2.85 $2.63 $2.76 829 100
Mar 18, 2016 $2.62 $2.74 $2.50 $2.63 2 307 900
Mar 17, 2016 $2.45 $2.64 $2.36 $2.59 1 324 800
Mar 16, 2016 $2.44 $2.58 $2.37 $2.44 1 355 200
Mar 15, 2016 $2.76 $2.76 $2.51 $2.55 1 310 100
Mar 14, 2016 $2.81 $2.90 $2.70 $2.79 942 400
Mar 11, 2016 $2.71 $2.84 $2.68 $2.83 1 079 600
Mar 10, 2016 $2.80 $2.81 $2.61 $2.67 753 800
Mar 09, 2016 $2.91 $2.99 $2.68 $2.76 1 570 300
Mar 08, 2016 $3.12 $3.15 $2.75 $2.87 2 948 700
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT